FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

5011411000001103: Tritace 10mg tablets (Aventis Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18549501000001115 Tritace 10mg tablets (Aventis Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66023401000001115 Tritace 10mg tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tritace 10mg tablets (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) Is a Product containing precisely ramipril 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) Has active ingredient Ramipril false Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) Is a Tritace true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) Has specific active ingredient Ramipril true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tritace 10mg tablets (Aventis Pharma) 28 tablet Is pack of False Tritace 10mg tablets (Aventis Pharma) Inferred relationship Existential restriction modifier
Tritace 10mg tablets (sanofi-aventis) 7 tablet Is pack of False Tritace 10mg tablets (Aventis Pharma) Inferred relationship Existential restriction modifier
Tritace 10mg tablets (sanofi-aventis) 7 tablet Has AMP True Tritace 10mg tablets (Aventis Pharma) Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Aventis Pharma) 28 tablet Has AMP True Tritace 10mg tablets (Aventis Pharma) Inferred relationship Existential restriction modifier
Tritace 10mg tablets (Sanofi) 10 tablet Has AMP True Tritace 10mg tablets (Aventis Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start